 FARMINGDALE, N.Y., March 01, 2021 GLOBE NEWSWIRE -- Misonix, Inc. NASDAQ: MSON, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Cowen 41st Annual Healthcare Conference and the Oppenheimer 31st Annual Healthcare Conference on March 4th and March 16th, respectively. Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be available to host one-on-one meetings with investors who are registered to attend the conferences. 